elotuzumab 400 MG Injection

RxCUI
1726117
RxNorm name
elotuzumab 400 MG Injection
Display name
elotuzumab 400 MG Injection
Full name
elotuzumab 400 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761035Emplicitielotuzumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EMPLICITIELOTUZUMABE.R. Squibb & Sons, L.L.C.80686b7e-f6f4-4154-b5c0-c846425e2d912022-03-22Warnings, Adverse reactionsExact identifier
rxcui: 1726117

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
80686b7e-f6f4-4154-b5c0-c846425e2d91elotuzumab 400 MG Injection [PSN] · elotuzumab 400 MG Injection [SCD]213These highlights do not include all the information needed to use EMPLICITI safely and effectively. See full prescribing information for EMPLICITI. EMPLICITI ® (elotuzumab) for injection, for intravenous use Initial U.S. Approval: 201520220322